Get startedLog in
    Picture of ANG Lifesciences India logo

    540694 — ANG Lifesciences India Income Statement

    0.000.00%
    in flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapTurnaround
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual income statement for ANG Lifesciences India, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

    2022
    March 31st
    2023
    March 31st
    2024
    March 31st
    2025
    March 31st
    2026
    March 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSARS
    Standards:
    IAS
    IAS
    IAS
    IAS
    IAS
    Status:FinalFinalFinalFinalFinal
    Revenue
    Total Revenue3,5432,1991,461928929
    Cost of Revenue
    Gross Profit1,263621510332324
    Selling / General / Administrative Expenses
    Depreciation and Amortization
    Unusual Expense / Income
    Other Operating Expenses
    Total Operating Expenses2,9272,0641,4661,019985
    Operating Profit616135-4.55-90.3-56.2
    Total Net Non Operating Interest Income / Expense
    Gain / Loss on Sale of Assets
    Total Net Non Operating Interest Income / Expense
    Other Net Non Operating Costs
    Net Income Before Taxes53526.3-107-157-130
    Provision for Income Taxes
    Net Income After Taxes403-2.62-101-124-111
    Net Income Before Extraordinary Items
    Net Income403-2.62-101-124-111
    Adjustments to Net Income
    Income Available to Common Shareholders Excluding Extraordinary Items
    Income Available to Common Shareholders Including Extraordinary Items
    Diluted Net Income403-2.62-101-124-111
    Diluted Weighted Average Shares
    Basic EPS Including Extraordinary Items
    Diluted EPS Including Extraordinary Items
    Diluted EPS Excluding Extraordinary Items
    Normalised Income Before Taxes
    Normalised Income After Taxes
    Normalised Income Available to Common Shareholders
    Diluted Normalised EPS31.2-4.73-6.99-9.51-8.5
    Dividends per Share